ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 636373 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 636373; 2) Community: the network communities that were significantly associated with the response to NSC 636373; 3) Molecule: the relationships between components within communities and NSC 636373; 4) MDR: the compounds that were significantly associated with the NSC 636373.

NSC Compound Enrichment Correlation
NSC 713750 Null 0.0195202843390059 0.12858126
NSC 102627 Yoshi 864 0.0195202843390061 -0.11841958
NSC 139021 1-(2-Thiazolylazo)-2-naphthol 0.0195202843390061 0.14843309
NSC 175630 Toyocamycin, 6-amino- 0.0195202843390061 0.20032548
NSC 191909 .alpha.-Chloro-N-(p-methoxyphenyl)succinimide 0.0195202843390061 0.28690186
NSC 328403 Acetamide, N-(4-formyl-5,6,7,9-tetrahydro-1,2,3,10- tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0195202843390061 -0.049816958
NSC 331122 Zonarol 0.0195202843390061 0.23419761
NSC 381866 BAFILOMYCIN DERIV. 0.0195202843390061 -0.009000676
NSC 657598 Thiazolo[2,3-b]thiazolium, 2,3-dihydro- 2-[(4-nitrophenyl)methylene]- 5-(3-nitrophenyl)-3-oxo-, chloride 0.0195202843390063 0.16583309
NSC 667449 Null 0.0195202843390063 0.14915919
Total:39  Current:13    [First] [Prev] [Next] [Last]